The company plans to commercialize a gene expression signature to predict recurrence risk in cutaneous squamous cell carcinoma.

Skin cancer screening

Following validation, the approach, which uses a deep convolutional neural network trained with almost 130,000 clinical images, could be developed into a smartphone app to detect skin cancer early.